​

Protara Therapeutics Ownership | Who Owns Protara Therapeutics?

OverviewForecastRevenueFinancialsChart

Protara Therapeutics Ownership Summary

Protara Therapeutics is owned by 70.30% institutional investors, 2.79% insiders, and 26.92% retail investors. Janus henderson group is the largest institutional shareholder, holding 10.17% of TARA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.60% of its assets in Protara Therapeutics shares.

TARA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockProtara Therapeutics70.30%2.79%26.92%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group2.27M10.17%$11.94M
Opaleye management1.82M8.17%$9.64M
Boxer capital811.63K7.11%$1.69M
Velan capital investment management lp1.58M7.07%$8.34M
Vanguard group1.36M6.09%$7.18M
Blackrock funding, inc. /de2.14M5.07%$6.50M
Blackstone1.91M4.52%$5.79M
Woodline partners lp853.16K3.82%$4.50M
5am venture management800.00K3.58%$4.22M
Integral health asset management1.40M3.31%$4.24M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp1.58M7.19%$8.34M
Opaleye management1.82M1.69%$9.64M
Superstring capital management lp360.00K1.29%$1.09M
Stempoint capital lp1.14M1.11%$3.47M
5am venture management800.00K1.01%$4.22M
Cvi302.75K0.54%$629.71K
Integral health asset management1.40M0.39%$4.24M
Boxer capital811.63K0.09%$1.69M
Adar1 capital management122.69K0.06%$371.75K
Ra capital management1.04M0.05%$3.15M

Top Buyers

HolderShares% AssetsChange
Janus henderson group2.27M0.01%2.27M
Blackrock funding, inc. /de2.14M0.00%1.51M
Velan capital investment management lp1.58M7.19%1.00M
5am venture management800.00K1.01%800.00K
Boxer capital811.63K0.09%602.40K

Top Sellers

HolderShares% AssetsChange
Ra capital management1.04M0.05%-2.36M
Toronto dominion bank---2.09M
Sio capital management---1.51M
Armistice capital---520.00K
Ikarian capital---350.49K

New Positions

HolderShares% AssetsChangeValue
Janus henderson group2.27M0.01%2.27M$11.94M
5am venture management800.00K1.01%800.00K$4.22M
Marshall wace, llp362.53K0.00%362.53K$1.10M
Cvi302.75K0.54%302.75K$629.71K
Goldman sachs group203.22K0.00%203.22K$1.07M

Sold Out

HolderChange
Jpmorgan chase-22.00
Advisor group-100.00
Acadian asset management-6.31K
Commonwealth equity services-10.00K
Wolverine trading-10.70K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20258128.57%29,714,8836.28%701.49%5365.63%1416.67%
Mar 31, 202564-28,759,849-3.07%700.40%33-26.67%1220.00%
Dec 31, 202412-66.67%2,074,529-80.14%90.42%8-55.56%3-57.14%
Sep 30, 202436-14.29%10,447,278-0.02%460.56%18-28.00%7-12.50%
Jun 30, 2024427.69%10,449,817128.63%915.62%2556.25%8-11.11%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.00M2.60%-22.12K
Vanguard US Total Market Shares ETF616.30K1.74%-
iShares Russell 2000 ETF633.30K1.64%-12.07K
Vanguard Institutional Extnd Mkt Idx Tr363.24K0.94%-165.52K
iShares Russell 2000 Value ETF278.47K0.72%207.00
A4Investments SICAV SIF ACCI IlanaA2EURH125.00K0.61%-
Fidelity Extended Market Index170.78K0.44%-446.00
Vanguard Russell 2000 ETF155.34K0.40%-9.01K
State St Russell Sm Cap® Indx SL Cl I113.10K0.29%-
BlackRock Extended Equity Market K54.38K0.26%-23.00

Recent Insider Transactions

DateNameRoleActivityValue
May 14, 2025Levy Richard S-Buy$63.80K
Mar 26, 2025Zummo Jacqueline Chf Scientific Operations OffSell$96.14K
Sep 11, 2024Opaleye Management Inc.-Sell$2.74K
Sep 12, 2024Opaleye Management Inc.-Sell$204.73K
Sep 12, 2024Opaleye Management Inc.-Sell$11.11K

Insider Transactions Trends

DateBuySell
2025 Q21-
2025 Q1-1
2024 Q3-18
2024 Q2-18
2024 Q1--

TARA Ownership FAQ

Who Owns Protara Therapeutics?

Protara Therapeutics shareholders are primarily institutional investors at 70.30%, followed by 2.79% insiders and 26.91% retail investors. The average institutional ownership in Protara Therapeutics's industry, Biotech Stocks , is 304.14%, which Protara Therapeutics falls below.

Who owns the most shares of Protara Therapeutics?

Protara Therapeutics’s largest shareholders are Janus henderson group (2.27M shares, 10.17%), Opaleye management (1.82M shares, 8.17%), and Boxer capital (811.63K shares, 7.11%). Together, they hold 25.45% of Protara Therapeutics’s total shares outstanding.

Does Blackrock own Protara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Protara Therapeutics.

Who is Protara Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Protara Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.19% of its assets in 1.58M Protara Therapeutics shares, valued at 8.34M$.

Who is the top mutual fund holder of Protara Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Protara Therapeutics shares, with 2.60% of its total shares outstanding invested in 1M Protara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools